In one of the largest licensing deals in the Australian biotechnology industry, Dimerix (ASX:DXB) has signed an exclusive US licence agreement with Amicus Therapeutics to commercialise its kidney disease drug candidate DMX-200. …
Dimerix secures one of the largest licensing deals in Australian biotechnology
May 1, 2025 Australian Biotech
Latest Video
New Stories
-
The Dispatched 'Week in Review' Podcast - 2 May
May 2, 2025 - - Podcast -
Major parties share commitment to the HTA Review process and no pre-election funding
May 1, 2025 - - Latest News -
Dimerix secures one of the largest licensing deals in Australian biotechnology
May 1, 2025 - - Australian Biotech -
New report shows US government more interested in cheese names than the PBS
May 1, 2025 - - Latest News -
Merck Healthcare leader joins Brain Cancer Australia charity board
April 30, 2025 - - Latest News -
Icon partners with Nuffield Health for three new cancer centres
April 30, 2025 - - Latest News -
PBS listing for Otsuka and Lundbeck's long-acting injectable for schizophrenia
April 30, 2025 - - Latest News